Proposed LCD DL40278: MolDX: Non-Next Generation Sequencing Targeted Molecular Panel Tests for Predictive Testing in Cancer — WPS
Policy LCD-DL40278 · Oncology
New LCD may impact billing for cancer genomic tests.
Code intelligence
Policy changes, MAC LCD updates, and CMS guidance matched to code C34.91.
Signal breakdown
7 shown · 7 total in platform
Critical
0%
High
14%
Routine
86%
Low
0%
New this month
—
alerts added in last 30 days
Effective soon
—
no upcoming deadlines
Policy LCD-DL40278 · Oncology
New LCD may impact billing for cancer genomic tests.
Policy LCD-L39230 · Oncology
New LCD may transform oncology billing with advanced testing.
Policy LCD-L37921 · Oncology
New liquid biopsy tests for lung cancer effective Nov 2025.
Policy LCD-L37897 · Oncology
New liquid biopsy tests for lung cancer impact billing.
Policy LCD-L38327 · Oncology
New billing guidelines for lung cancer genomic testing.
Policy LCD-L38238 · Oncology
New billing guidelines for lung cancer tests effective July 2025.
Policy LCD-L38329 · Oncology
New billing guidelines for lung cancer genetic testing effective in 2025.
Audit documentation
The Tripwire Audit Pack exports 12 months of Oncology policy-change history — every alert with a link to its government source document, as a formatted PDF for compliance distribution plus a machine-readable CSV. Delivered automatically after payment. No account, no call.